chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 1:12 pm, RRT was called and 4 RNs responded to the scene. Stethoscope, pulse ox, and emergency kit brought to scene. Client reports feeling pins and needles in the back of her head. She feels that her tongue and neck are swollen but as assessed, they were not swollen. She also reports feeling tingling in her tongue and neck. She was AAOx4, in no acute distress, no SOB noted. Skin and lip color normal, cap refill <3 seconds. Heart and lung sounds normal. Vitals: BP: 128/80, HR: 90, O2: 99% on RA, RR: 18. She did not report any pain. EMS was not called at this time. It was decided by RRT team that client can be monitored for an additional 30 minutes. RN stayed with client throughout 30-minute monitoring period. RN stated that during monitoring period, client was fine but kept reporting that she felt a lump in her throat. Husband talking with RN revealed that client is not diagnosed with anxiety but does have it. At the end of her 30-minute monitoring period at 1:40 pm, RRT was called again. RN already with client and client reported that she felt tingling everywhere again all over her body and felt like she could not breathe. Additionally, she had that feeling of being embarrassed with the sudden rush of heat throughout her body. Additional RN's arrived to scene at 1:41 pm. Upon assessment, she was not SOB but had rapid breathing associated with anxiousness and nervousness, which she reported. RN noticed client's hands and arms were shaking and client stated it was because she was nervous. Client speaking in full sentences. At this point, RRT RNs decided that client needs 911 assistance which was activated by Fire Chief on site. RNs also assessed that client's tongue was swollen again. Heart and lungs sounds were normal. Vitals at 1:49 pm: HR: 102, BP: 144/70, O2: 95%, RR: 21. At this point, on the basis of the symptoms she was experiencing, RN's decided to administer Benadryl 50 mg IM that was in the emergency kit. When the decision was made, client was asked if it was okay to administer Benadryl IM. She was explained the purpose of Benadryl, the side effects, and risks and benefits. Client consented to receiving Benadryl IM. Benadryl 50 mg IM administered to RA by RN at 13:51. By 13:53, her tongue was not swollen anymore. At 13:58, she was not SOB anymore, talking in full sentences, no acute distress, tingling stopped. By 13:59, the same symptoms of tingling throughout her body, feeling a sudden heat rush throughout her body started again. HR: 65, RR: 21, O2 95%. At 14:01, EMS arrives, truck number 341, vitals stable on their end. At 14:04, client decided to go to RUHS via ambulance. One of the paramedics stated that client's hands were "cold as ice". At 14:07, report was given to paramedics/ambulance and client was in the ambulance. Care assumed by ambulance/paramedics.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Sjrogrens" (unspecified if ongoing); "Known allergies: Latex" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Known allergies:codeine, reaction(s): "Drug Allergy"; Known allergies: iodine, reaction(s): "Drug Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: unknon results, notes: indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Administered TDAP. Immediately turned pale in color, passed out, body stiffened like he was having a seizure. Lasted seconds. Pt kept here for 30 min. following episode. BP/Pulse taken after 5 min. Pt. drank a SPRITE and ate peanut butter crackers and was fine. Left with friend.
Got vaccine on 3/17, on 3/22 presented to the ED with a diffuse rash most consistent with erythema multiforme
Got a dose of the Johnson and Johnson Covid-19 Vaccine, then got 2 full doses of Moderna Covid-19 Vaccine 2 months apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got a dose of the Johnson and Johnson Covid-19 Vaccine, then got 2 full doses of Moderna Covid-19 Vaccine 2 months apart) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 076C21A and 045J21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE on 19-Mar-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE.   On 23-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got a dose of the Johnson and Johnson Covid-19 Vaccine, then got 2 full doses of Moderna Covid-19 Vaccine 2 months apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got a dose of the Johnson and Johnson Covid-19 Vaccine, then got 2 full doses of Moderna Covid-19 Vaccine 2 months apart) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
MCV4 #1 was administered on L/arm. Pt. had a local reaction to site (red swollen).
Patient says 45 minutes after receiving the vaccine her eyes and lips started swelling, she was burning from head to toe and had localized reaction at the injection site.  She had an Epi-Pen on hand due to the previous reaction she had to Shingrix (which again we were not aware of). She used the Epi-Pen, took steroids, and Benadryl.
It was so painful; My arm still hurts; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Covid (received covid vaccine on an unknown date) and pneumonia (received pneumonia vaccine on an unknown date).   On 20th September 2022, the patient received the 1st dose of Shingles vaccine. In September 2022, less than a week after receiving Shingles vaccine, the patient experienced pain and pain in arm. On an unknown date, the outcome of the pain and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the pain and pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR140045   Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's Comments: The patient self-reported this case via interactive digital media. The patient got his/her 1 shot on Tuesday (from the date of reporting) it was so painful his/her arm still hurts.  The patient got all the vaccines flu, Covid, pneumonia and this by far was the worse, the doctor on Wednesday gave the flu shot not a problem.  The patient got 1st vaccine and it was worse shot the patient ever had, and on the day of reporting got the flu shot piece of cake. Additional Supportive Information: The follow-up would not possible, as no contact, details were available.; Sender's Comments:  US-GSK-US2022AMR140045:Same reporter
Starting in the beginning of a December, I felt a lump in my neck. I waited to go in due to insurance issues. It persisted and I was getting concerned. On 02/21/2022, I went in to my PCPs office and they ran blood work (WBC was high). Ran blood work again and noticed WBC count was down but that my kidney and liver numbers were high. I had an ultrasound done of my thyroid showing an enlarged thyroid with several nodules on the right side. I have yet to see the specialist for it.
Had the shots, still got shingles/Suspected vaccination failure; Shingles/ Still got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shots and still got the shingles. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Pt w/sharp chest pain 1 day after vaccination + palpitations. Chest pain worse with laying back. Symptoms persisting into 1/13/22, though much improved. Echo 1/13/22 reveals trivial pericardial effusion. Suspect vaccine-induced pericarditis.
This spontaneous report was received from a medical assistant and refers to an unknown number of patients of unknown age and gender. The patients' concomitant medications, pertinent medical history and drug reaction or allergies were not provided. On unknown dates in 2017 (reported as "on unspecified dates since 12-FEB-2017"), the patients were vaccinated with improperly stored doses of ROTATEQ, lot # M016238 with expiry date 07-DEC-2017, orally (exact dose was not reported). The doses were exposed to the temperature between 0 and 1 degree Celsius (0.5 degree Celsius) for 3 hours and 55 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse experience had been reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA004336.
Febrile seizure that lasted 10 minutes long. Fever of 104.7. Seizure happend at 1:00 AM.
fever 102+, chills, headache, nausea, diarrhea, muscle/joint aches - all lasted 3-4 days second shot administered: 10/11/2019 - pre-medicated w/Tylenol - same symptoms but not as severe - fever 101, chills, muscle/joint aches, headache, no nausea
injection site pain; headache; tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 04Mar2021 09:45 (Lot number: EL3247) at the age of 41 years as dose 1, single for covid-19 immunization.   Relevant medical history included: "headaches/migraine" (unspecified if ongoing); "headaches/migraine" (unspecified if ongoing); "Known allergy/ penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 04Mar2021, outcome "recovering", described as "injection site pain"; HEADACHE (non-serious) with onset 04Mar2021, outcome "recovering", described as "headache"; FATIGUE (non-serious) with onset 04Mar2021, outcome "recovering", described as "tiredness". Therapeutic measures were taken as a result of vaccination site pain, headache, fatigue.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received birth control medication within 2 weeks of vaccination. She received ibuprofen for the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. She had not been tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
HCP calling to report vaccine administered after temperature excursion and before temperature excursion evaluation occured; Information has been received from a medical assistant regarding a 5 years-old patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 26-AUG-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) injection, for prophylaxis, (lot number S006830 with expiration date in 02-SEP-2020) (dose, route of administration, strength and anatomical location were not reported) after temperature excursion and before temperature excursion evaluation occurred.  The measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) was stored at a temperature of 5 degrees Celsius (°C) for the time frame of 12 hours. There was a previous temperature excursion of 8.4 degrees Fahrenheit for the time frame of 60 hours and the call was because of a data logger.
Large red rash at injection site 8 days following the shot. Hives on body 9 days following the shot, starting at the hands at feet primarily, and then also spreading to legs and arms.
pt recvd vax 7DEC95 1145AM & 1-130PM pt became irritable, face reddened, lt leg tender to touch;230 APAP given T105 warm tepid bath given & pedialyte;mom contacted MD who ordered motrin;7AM t102, 12noon t100-101; devel rhinnorrhea
Swollen arm; Redness on her arm; Feel crappy; Headache; Chills; Exhaustion, fatigue; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of peripheral swelling (1st dose received in September 2022, refer case US2022AMR196013).   On 26th December 2022, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced swelling arm, erythema of extremities, feeling bad, headache, chills and fatigue. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the swelling arm, erythema of extremities, feeling bad, headache, chills and fatigue were not recovered/not resolved.   It was unknown if the reporter considered the swelling arm, erythema of extremities, feeling bad, headache, chills and fatigue to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR196013   Additional Information: GSK Receipt Date: 30-DEC-2022  Reporter's Comments: The patient got 2nd shot of Shingrix on Monday and still felt crappy.      She also experienced a swollen arm, redness on her arm, exhaustion, headache, chills and fatigue which had not yet resolved. The reporter asked how long the side effects of vaccine would last? The reporter had not given consent to follow up.; Sender's Comments:  US-GSK-US2022AMR196013:Same reporter
This case was reported by a nurse and described an adult female subject who did not respond to immunization to Engerix-B for prophylaxis.  The nurse reported that, "several years" prior to January 2005, the subject, "had the full hepatitis B (unknown manufacturer) series." On 25 January 2005, the subject, "had a needle stick injury" and subsequently received the 4th "booster" dose of Engerix-B (lot AHBVB004AA). On an unspecified date is July 2005, approximately 5 months after vaccination with the 4th dose of Engerix-B, a hepatitis B surface antibody titer was negative.
10/13/21 1pm Pharmacy got Pfizer shot 10/13/21 mild headache within 2 hours 10/14/21 bad headache the entire day. No arm soreness.  10/15 teaching all day and felt pain on right side.  10/16-10/17 still pain on right side and armpit 10/18 teaching all day With the pain 10/18 5pm feeling pain down back of right leg down through heal. Tingling. Numbness. Deep tissue pain right but cheek.  10/19 called dr 3x to tell of pain. No call back  10/20 9:00am. Primary dr sent me to emergency room for Nerve tests/scans.   Ekg, chest  X-ray, given   Valume amd toroidal given. Dr release Me ans said it was muscular. I strained my sciatica somehow he said. He would not discuss with me if it could hane possible been due to vaccine a few days prior.  600mg iniprophen given as prescription amd a muscle relaxer as well   Today is 10/23/21. I still have pain on right side that radiates from arm pit through chest and parricularly painful Down right leg. Increasing in severity to a 10 At times
2:13 pm client verbalized feeling lightheaded and nauseous,  2:14 pm Client assessed by Fire Rescue.  2:16 pm Client observed for 15 additional mins.  2:31 pm Per paramedics symptoms resolved and released to go home.
severe asthma attack; throwing up; head rush/dizziness; fever; fatigue/slept all the rest of the day; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration administered in left arm on 30Mar2021 at 12:00 (at 59 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included asthma, hypersensitivity, and high blood pressure; all from unspecified date. The patient had no known allergies. Concomitant medication included beclometasone dipropionate (QVAR) and antihistamines, both from unspecified date for unspecified indication. The patient did not have COVID-19 prior to vaccination. The patient was not tested for COVID-19 post vaccination. The patient reported that approximately 48 hours after vaccine dose, the patient experienced a severe asthma attack including throwing up and having to use albuterol sulfate nebulizer. Note: Day of vaccine the patient had severe cytokine-antivirus response symptoms with head rush, dizziness, fever, fatigue, slept all the rest of the day. The date of adverse events was on 31Mar2021 at 12:00. Outcome of the events was recovered on unspecified date in 2021.   Information on batch/lot number has been requested.
around 1500 Vomited x 1; HTN  190's/ 116-118; flush cheeks bilaterally; dizzy; weak;
I woke up at 2:00am the following morning after receiving the first vaccine with severe body aches, joint and muscle pain, migraine headache, fever of 100.4 and nausea with abdominal pain. By 10:00am that morning all of my lymph nodes were swollen and painful with the biggest one being under my left arm pit and was the size of a baseball. I continued to have chest pain on the left side of my chest, severe headaches, pain under my armpit and brain fog for the next 10 days before symptoms subsided.
5 days after getting the vaccine I began to feel a scratchy throat and developed a mild cough. The symptoms quickly developed into sore throat, more severe and productive cough, achiness, lethargy, severe headache, bilateral conjunctivitis, ear pain, chest pain, shortness of breath, fullness in the chest and the head and a low grade fever of 99.2-99.8
Immediately shooting electrical pains in top right back of head x 7 days. Then dull aches continuing at time of report.
PERIPHERAL NEUROPATHY 3/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
PNEUMOVAX vaccine adm (R) deltoid on 8/31/11, later the same day pt developed swelling, tenderness & redness at site and surrounding area. Pt was examined in office on 9/1/11, (R) upper arm noted to be reddened, warm to touch & tender no fever no drng at injection site, Rx for KEFLEX given. On 9/2/11 pt c/o increase redness & increase pain & was advised to go ER ---> Pt admitted.
Onset of rash started on face with swelling of the eyebrows, cheeks and onto the neck. She sent pictures to her PCP and was given steroid BID for 7 days. Started a tapering dose of the medication and benadryl as needed. She was seen by Dermatology after steroid treatment. Steroid cream given (hydrocortisone) without improvement. She is using another steroid cream which seems to be working. Rash still present on the cheeks. She is now repeated another round of oral steroids.
pt recv vax & 55min p/vax pt exp a red raised rash around the inj site 4cm in diameter;rash cleared p/few days;
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 06-FEB-2015, the patient received the ZOSTAVAX (lot number, dosage and route of administration not provided) for its intended purpose: the prevention of shingles. As a direct result of the ZOSTAVAX, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of her body. The patient had her first shingles outbreak on 10-MAY-2016. On 21-OCT-2016, the patient was diagnosed with neuropathic disorder causing her pain and was prescribed gabapentin for the pain. As a direct result of the vaccine, the patient suffered and continues to suffer mental and emotional distress due to resulting physical limitations and the seriousness of her condition. As a result of the ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate consequence of the ZOSTAVAX vaccine, the patient sustained serious personal injuries and related losses including, but not limited to, mental anguish, physical pain and suffering, diminished capacity for the enjoyment of life, a diminished quality of life, medical and related expenses, and other losses and damages. Upon internal review, neuropathic disorder was determined to be medically significant. Shingles outbreak and neuropathic disorder were considered to be disabling. Additional information has been requested.
My period disappeared. In the month following receiving the vaccine, I barely had spotting and wasn't even sure if I was menstruating so my doctor had me get hormone tests via OB-GYN Dr.    I was told I was peri menopausal and no longer producing eggs.
Per MD note, 2/28/18: 10/12/17 left shoulder injury after vaccination. She is a disabled MD and has done some investigating believes this to be: SIRVA (shoulder injury related to vaccine administration). She reports immediately at the time of administration, she felt the vaccine had been placed too high on the arm and actually felt intra-articular. Worsening pain, dysfunction and limited motion followed subsequently. H/O remote FOOSH injury 1995-6 injuries bilateral shoulders, no other trauma, can't even make the bed. Started feeling slightly better in the last 2-4 weeks. Doing diclofenac BID. Heating pad BID. ROM exercises started within a few days. Pain even just with dependency as the arm hangs at rest. Lipoma on same shoulder non new. Review of previous records 4x5 cm -- unchanged.
Terrible pain in temple, throat & chest; initially MD prescribed DPH pills but these made her sick to stomach; had difficult breathing & chest hurt; To ER @ hosp 21SEp91; poss congestive heart failure admitted;